Bellevue Group »

Supernus Pharmaceuticals shares owned by Bellevue Group

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $437k 15k 28.94
2023-09-30 $16M 581k 27.57
2023-06-30 $20M 650k 30.06
2023-03-31 $4.5M 123k 36.23
2022-12-31 $4.0M 111k 35.67
2022-09-30 $4.0M 119k 33.85
2022-06-30 $2.4M 82k 28.92
2022-03-31 $1.9M 59k 32.32
2020-03-31 $9.9M 553k 17.99
2019-12-31 $14M 576k 23.72
2019-09-30 $11M 417k 27.48
2019-06-30 $16M 467k 33.09
2019-03-31 $10M 291k 35.04
2018-12-31 $12M 345k 33.22
2018-09-30 $20M 387k 50.35
2018-06-30 $20M 327k 59.85
2018-03-31 $13M 289k 45.80
2017-12-31 $9.6M 240k 39.85
2016-06-30 $3.3M 164k 20.37
2016-03-31 $6.7M 441k 15.25